@article{TAU30381,
author = {Geert J. L. H. van Leenders},
title = {PD-L1 testing in urothelial carcinoma: are we there yet?},
journal = {Translational Andrology and Urology},
volume = {8},
number = {Suppl 5},
year = {2019},
keywords = {},
abstract = {Cisplatinum-based chemotherapy is the standard treatment modality of patients with locally advanced or metastatic urothelial cell carcinoma. Due to its toxicity, however, a significant number of patients is ineligible for this treatment.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/30381}
}